Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations. Polan RM, Ali-Fehmi R, Grace AK, Mattei LH, et al. Gynecol Oncol 2024;189:37-40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Polan RM, Ali-Fehmi R, Grace AK, Mattei LH, et al. Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations. Gynecol Oncol 2024;189:37-40.
PMID: 39003959